Literature DB >> 28994827

Bladder cancer: Mastering the immune microenvironment.

Louise Stone.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28994827     DOI: 10.1038/nrurol.2017.166

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS: Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer.

Authors:  Alexander C Dowell; Ellen Cobby; Kaisheng Wen; Adam J Devall; Vinnie During; Jane Anderson; Nicholas D James; Kar K Cheng; Maurice P Zeegers; Richard T Bryan; Graham S Taylor
Journal:  PLoS One       Date:  2017-09-20       Impact factor: 3.240

  1 in total
  4 in total

1.  A prognosis marker MUC1 correlates with metabolism and drug resistance in bladder cancer: a bioinformatics research.

Authors:  Liangliang Qing; Qingchao Li; Yongjin Yang; Wenbo Xu; Zhilong Dong
Journal:  BMC Urol       Date:  2022-07-25       Impact factor: 2.090

2.  Bacillus Calmette-Guérin-Induced Human Mast Cell Activation Relies on IL-33 Priming.

Authors:  Karen M Garcia-Rodriguez; Anu Goenka; Darren D Thomson; Rajia Bahri; Chiara Tontini; Barbora Salcman; Rogelio Hernandez-Pando; Silvia Bulfone-Paus
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

3.  Profiles of Immune Infiltration in Bladder Cancer and its Clinical Significance: an Integrative Genomic Analysis.

Authors:  Zonglong Wu; Kejia Zhu; Qinggang Liu; Yaxiao Liu; Lipeng Chen; Jianfeng Cui; Hongda Guo; Nan Zhou; Yaofeng Zhu; Yan Li; Benkang Shi
Journal:  Int J Med Sci       Date:  2020-03-05       Impact factor: 3.738

4.  circ-FNTA accelerates proliferation and invasion of bladder cancer.

Authors:  Jianhai Tian; Jiqiang Fan; Jianping Xu; Tong Ren; Huaiyuan Guo; Lulian Zhou
Journal:  Oncol Lett       Date:  2019-11-27       Impact factor: 2.967

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.